Evaluation of factors influencing the quality and efficacy of ultrasound and phonophoresis treatment;Ocena czynników wpływajacych na jakość i skuteczność stosowania terapii ultradźwiekowej i fonoforezy

Ortopedia Traumatologia Rehabilitacja

Volumn 9, Issue 5, 2007, Pages 449-458

  Goraj Szczypiorowska, Barbara ^a,b   Zajac, Lidia ^b   Skalska Izdebska, Renata ^c  

^a STOCER Prof M Weiss Memorial Rehabilitation Centre   (Poland)

^b Mazowiecka College   (Poland)

^c Centre for Education and Rehabilitation   (Poland)

Author keywords

Physiotherapy; Results; Ultrasound treatment

Indexed keywords

SALICYLIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL EFFECTIVENESS; DERMIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; EPIDERMIS; HOMEOSTASIS; HUMAN; MEDICAL DECISION MAKING; PHYSIOTHERAPY; QUALITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ULTRASOUND THERAPY; DOSE RESPONSE; EVIDENCE BASED MEDICINE; METHODOLOGY; PAIN; PAIN ASSESSMENT; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION; ULTRASOUND;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; PAIN; PAIN MEASUREMENT; PHONOPHORESIS; PHYSICAL THERAPY MODALITIES; SKIN ABSORPTION; ULTRASONIC THERAPY;

EID: 43049158223     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Chien YW. Developmental concepts and practice in transdermal therapeutic systems. In: Chien YW, ed. Transdermal Controlled Systemic Medications: Vol. 31, New York, Marcel Dekker Inc, 1987, Ch. 2, 25-82
2. Maleche AN, DelTerza S, Higuchi WI, Srinivasan T. Iontophoretic drug delivery: effect of physiocochemical effects on skin uptake of drugs. In: Osborne D. W., Amann A. H. eds. Topical drug Delivery Formulations: Vol. 42. New York, Marcel Dekker Inc. 1990, Ch. 35, 633-52
3. Mika T, Kasprzak W. Fizykoterapia. PZWL, 2001.
4. Straburzyński G, Straburzyńska-Lupa A. Medycyna Fizykalna. PZWL, wyd. II, 2000
5. Kost J, Levy D, Langer R. Ultrasound as a transdermal enhancer. In: Osborne D. W. Amann A. H., eds. Topical Drug Delivery Formulations: Vol. 42 New York, Marcel Dekker Inc. 1990, Ch, 34, 603-32
6. Felllinger K, Schmid J, Klink und Therapie des Chronischen Gelenkhuermatismum Vienna, Austia, Maudrich (Austrian); 1954.
7. Kaczyński A, Lisiewicz H, Mika T, Zaremba B. Ultradźwiçki w lecznictwie. PZWL, Warszawa 1969.
8. Benson HAE, McElnay JC, Harland R. Phonophoresis of lignocaine and prilocaine from Emla carem. Int J Pharm 1988; 44: 65-9.
9. Benson HAE, McElnay JC, Transmission of ultrasound energy through pharmaceutical products. Physiotherapy 1988; 74: 597-9.
10. Bommannan D, Menon GK, Okuyaman M, et al. Sonophoriesis: Examination of the mechanism of ultrasound - enhanced transdermal drug delivery. Pharmaceutical Research 1992; 8: 356-360.
11. Bommannan D, Okujama H, Stauffer P, Guy RU. Sonophoresis In: The use of high frequeultrasound to enhance transdermal drug delivery. Pharmaceutical Research 1992; 9: 559-564.
12. Byl N. The use of ultrasound as an enhancer for transcutaneous drug delivery: phonophoresis. Phys Ther 1995; 5: 539-553.
13. Davick JP, Martin RK, Albright JP. Distribution and deposition of tritiated cortisol using phonophoresis. Phys Ther 1988; 68: 1672-1675.
14. Roberts D. Transdermal drug delivery using iontophoresis. Orthop Nurs 1999; 4: 50-54.
15. Czernicki J, Woldańska-Okońska M, Mockałło W, Gabrysiak H, Klimkiewicz K. Ocena wyników leczenia fizykalnego chorych ze zmianami zwyrodnieniowymi stawów kolanowych jonoforeza z diklofenakiem. Fizjoterapia 1999; 7(3): 16-19.
16. Czernicki J, Woldańska-Okońska M, Mockałło W, Gabrysiak H, Klimkiewicz K. The result of physioterapy with diclofenac phonophoresis in pacients with gonarteosis, Balneologia Polska 2000; 42 (1-2): 31-37.
17. Gburek Z, Kustra A, Smerczak A. Wyniki zastosowania zelu "Bals Sulphur" w fonoforezie (ultrafonoforezie) w chorobie zwyrodnieniowej stawu barkowego i kolanowego. Balneologia Polska 2000; 42 (1-2): 66-73.
18. Ksiezopolska-Pietrzak K, Miller H, Pazdur-Ziecina K. Jonoforeza i fonoforeza w chorobach reumatycznych. Terapia 2000; Nr specj.: 7-9.
19. Sosnowski S, Lachowicz J, Kowalska A, Rakowski A, Wagner W, Kasprzak HA. Fastum-żel - lek pierwszego rzutu w urazach sportowych. Medycyna Sportowa 2000; 16 (6): 30-2.
20. Szczegielniak B, Szczegielniak J, Sułek K. Leki w żelach stosowane w ultrafonoforezie. Fizjoterapia 1999; 7 (1): 46-48.
21. Łazowski J. Podstawy fizykoterapii. AWF Wrocław 2000.
22. Williams AR. Ulrasound: Biological Effects and Potential Hazards. San Francisco, Calif, Academic Press Inc, 1983
23. Bommannan D, Menon GK, Okuyaman Elias PM, Guy RH. Sonophoresis. II. Examination of the mechanism of ultrasound-enhanced transdermal drug delivery. Pharmaceutical Res 1992; 4: 1043-7.
24. Dinno MA, Crum LA, Wu J. The effect of therapeutic ultrasound on the electrophysiologic parameters of frog skin. Med Biol 1989; 26: 461-70.
25. Kost J, Chen R., Langer R. Membrane permeability enhancement by ultrasound. In: Proceedings of the Third World Biomaterials Congress, Japan, 1988.
26. Lehman JF, DeLateur BJ, Stonebridge JB, Warren CG. Therapeutic temperature distibution produced by ultrasound as modified by dosage and Vol. of tissue exposed. Arch Phys Med 1967; 48: 662-6.
27. Nyborg WL. Mechanisms. In: Nyborg W. L., Ziskin M. C., eds. Biological Effects of Ultrasound. New York, Churchill Livingstone Inc, 1985, 23-33
28. Griffin J. E., Touchstone J. C. Low-intensity phonophoresis of cortisol in swine. Phys Ther 1968: 48: 1336-4429.
29. Benson HAE, McElnay JC, Harland R. Use of ultrasound to enhance percutaneous absoption of Benzydamine. Phys Ther 1989; 69: 113-8.
30. Bronaugh RL. A flow-through diffusion cell. In: Bronaugh R. L. Maibach H. I., eds. In Vitro Percutaneous Absorption: Principles Fundamentals, and Applications. Ann Arbor, Michigan, CRC Press. 1991, Ch. 3, 17-24.
31. Benson HAE, McElnay JC. A high-perforormance liquid chromatography assay, for the measurement of benzydamine hydrochloride in topical pharmaceutical preparations. J. Chromatogr 1987; 394: 395-9.
32. Ciccone CD, Leggin BG, Callamaro J. Effects of ultrasound and trolamine salicylate phonoporesis on delayed-onset muscle soreness. Phys Ther 1991; 71: 666-78.
33. Henley EL. Iontophoresis and phonophoresis transcutaneous drug delivery. Presented at the 65th Annual Conference of the American Physical Theapy Association, Anaheim, California, 1990.
34. Hua S-M, Liu T-K, Yu H-Y. Absorption of lidocaine following topical application in microvascular procedures in rabbits. J Orthop Res 1991; 9: 544-9.
35. McElnay JC, Kennedy TA, Harland R. et al. The effect of ultrasound on the percutaneous absorpition of lignocaine. Br J Clin Pharmacol 1985; 20: 421-4.
36. Moll MJ. A new approach to pain: lidocaine and Decadron with ultrasound. USAF Med Serv Digest 1979; 30: 8-11.
37. Pottenger FJ, Karalfa GL. Utilization of hydrocortisone phonophoresis in United States Army physical Therapy slinics. Milw Med 1989; 154: 355-8.
38. Hill DW, Richardson JD. Effectiveness of 10% trolamine salicylate cream on muscular soreness induced by a reproducible program pf weight training. J Orthop Sports Phys Ther 1989; 22: 19-23.
39. Smith W, Winn F, Paratte R, Comparative study using four modalities in shin splints treatments. J Orthop Sports Phys Ther 1986; 8: 77-80.
40. Griffin JE, Touchstone JC. Ultrasonic movement of cortisol into pig tissues: I: movement into sceletal muscle. Am J Phys Med 1963; 42: 77-85.
41. Traczyk W, Trzebisk A. Fizjologia człowieka z elementami fizjologii stosowanej i klinicznej. PZWL, Warszawa 2005.
42. Gronczewski J. Leczenie ultradźwiekami. PZWL Warszawa 1964.